SEC Form 4 · accession 0001144204-17-015691
Aeon Global Health Corp. · AGHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Varinder Singh Rathore
Director
Period of report
Mar 31, 2016
Accepted (ET)
Mar 20, 2017 · 8:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885074
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock OptionsF1 | $3.05 | Jun 30, 2016 | A | 4,365 | A | Jan 21, 2019 | Jun 30, 2026 | Common Stock | 4,365 | 4,365 | D |
| Director Stock OptionsF2 | $2.93 | Sep 1, 2016 | A | 1,250 | A | Jan 21, 2019 | Sep 1, 2026 | Common Stock | 1,250 | 1,250 | D |
| Director Stock OptionsF3 | $3.58 | Sep 30, 2016 | A | 5,090 | A | Jan 21, 2019 | Sep 30, 2026 | Common Stock | 5,090 | 5,090 | D |
| Director Stock OptionsF4 | $3.50 | Dec 31, 2016 | A | 3,819 | A | Jan 21, 2019 | Dec 31, 2026 | Common Stock | 3,819 | 3,819 | D |
Explanation of responses
- F1Represents issuance in lieu of cash director fees pursuant to the Company's 2011 Omnibus Equity Incentive Plan attributable to the reporting person's board service for the fiscal quarter ended June 30, 2016.
- F2Represents issuance of annual award under the Company's 2011 Omnibus Equity Incentive Plan pursuant to the Company's director compensation policy.
- F3Represents issuance in lieu of cash director fees pursuant to the Company's 2011 Omnibus Equity Incentive Plan attributable to the reporting person's board service for the fiscal quarter ended September 30, 2016.
- F4Represents issuance in lieu of cash director fees pursuant to the Company's 2011 Omnibus Equity Incentive Plan attributable to the reporting person's board service for the fiscal quarter ended December 31, 2016.
Remarks
Physical delivery of the option awards set forth in Table II of this Form 4 was not made to the reporting person until March 16, 2017.